Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 121,732	$ 190,505
Restricted cash, current	558	2,830
Accounts receivable, net	34,674	31,730
Inventory	125,158	130,336
Prepaid expenses and other current assets	13,016	12,904
Assets held for sale	2,275	4,539
Total current assets	297,413	372,844
Restricted cash, non-current	12,600	12,600
Property, plant, and equipment, net	188,115	194,046
Operating lease right-of-use assets	126,092	130,460
Prepaid lease costs, non-current	66,444	61,635
Other non-current assets, net	662	1,192
Investment in unconsolidated joint venture	1,612	1,673
Total assets	692,938	774,450
Current liabilities:
Accounts payable	59,633	56,032
Accrued bonus	345	4,790
Current portion of operating lease liabilities	4,103	3,677
Accrued litigation settlement costs	7,250	0
Accrued expenses and other current liabilities	15,260	9,855
Total current liabilities	86,591	74,354
Long-term liabilities:
Convertible senior notes, net	1,140,492	1,137,542
Operating lease liabilities, net of current portion	74,506	75,648
Finance lease obligations and other long-term liabilities	3,273	274
Total long-term liabilities	1,218,271	1,213,464
Commitments and Contingencies (Note 9)
Stockholders’ deficit:
Preferred stock, par value $0.0001 per share—500,000 shares authorized, none issued and outstanding	0	0
Common stock, par value $0.0001 per share—500,000,000 shares authorized; 65,171,128 and 64,624,140 shares issued and outstanding at September 28, 2024 and December 31, 2023, respectively	6	6
Additional paid-in capital	590,282	573,128
Accumulated deficit	(1,196,669)	(1,081,253)
Accumulated other comprehensive loss	(5,543)	(5,249)
Total stockholders’ deficit	(611,924)	(513,368)
Total liabilities and stockholders’ deficit	$ 692,938	$ 774,450